Mehrdad Abedi

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Non-viral precision T cell receptor replacement for personalized cell therapy”.

Non-viral precision T cell receptor replacement for personalized cell therapy

Nature(2022)10.1038/s41586-022-05531-1

N/A

4.1DataRank · unranked

281 citations

Kyle Jacoby, Daniela A. Bota, Theresa Hunter, Zheng Pan, Eric Stawiski +49 more

Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center

Frontiers in Oncology(2021)10.3389/fonc.2021.649209

N/A

0.606DataRank · unranked

56 citations

Benjamin N. Moskoff, David J. Benjamin, Rasmus T. Hoeg, Aaron S. Rosenberg, Mehrdad Abedi +3 more

Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects

Blood(2021)10.1182/blood.2021011216

N/A

0.425DataRank · unranked

16 citations

Logan V. Vick, Cordelia Dunai, Craig Collins, Shyam K. More, Catherine T. Le +12 more

A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.02.006

N/A

0DataRank · unranked

3 citations

JULIAN R. DAVIS, Brian A. Jonas, Joseph M. Tuscano, Aaron S. Rosenberg, Mehrdad Abedi +1 more

A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps8072

N/A

0DataRank · unranked

5 citations

Santosha A. Vardhana, Anita Kumar, Mehrdad Abedi, Rasmus T. Hoeg, Elad Sharon +2 more

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis

Blood Advances(2025)10.1182/bloodadvances.2025016845

N/A

0DataRank · unranked

2 citations

Tamer Othman, Paul Frankel, Christopher Ruel, Christina Poh, Samantha Herbert +20 more

Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility

Ophthalmology Science(2025)10.1016/j.xops.2025.100905

N/A

0DataRank · unranked

0 citations

Jennifer McCormack, Dagmar Salazar, Jacquie King, Marisa Salvador, Gerhard Bauer +10 more

Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation

Science Translational Medicine(2020)10.1126/scitranslmed.aay7713

N/A

0DataRank · unranked

50 citations

Catherine T. Le, Chien-Chun Steven Pai, Robin Shields‐Cutler, Shernan G. Holtan, Armin Rashidi +22 more

Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center

Leukemia Research(2022)10.1016/j.leukres.2022.106885

N/A

0DataRank · unranked

8 citations

Benjamin Moskoff, Gwendolyn Ho, Matthew E. Tenold, Tali Azenkot, Margaret L. Krackeler +12 more